Incellvu S.A.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-01-23
Share capital
3,306,050.00 PLN
Activity description

Incellvu is a company that develops innovative devices for ultra-fast volumetric imaging of the cellular structure of the human retina in vivo. They aim to create an optical coherence tomography (OCT) system for non-invasive imaging of the eye's structure and function with microscopic resolution, supporting the diagnosis of eye diseases and gene therapies to prevent vision loss. Their technology, known as spatio-temporal optical coherence tomography (STOC-T), allows for high-resolution imaging and functional analysis of the retina.

Registered address
ul. Skierniewicka 10A, 01-230 Warszawa, Poland
Social media
Electronic delivery address
AE:PL-26649-64477-HBFVG-23

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

Financial statements were filed on time, on average 17 days early. All were audited by a statutory auditor.

  • 202530/06/2026
  • 202426/06/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 82%
Top 89%
City · Warszawa48,684 / 56,729
Top 86%
Voivodeship · Mazowieckie67,090 / 76,892
Top 87%
Country · Poland263,526 / 297,069
Top 89%

Results vs industry

Revenue
This companyUSD 6.99kMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD -558.98kMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 564.59kMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 1.69mMedianUSD 281.58kAverageUSD 8.35m

Offer

  • Optical tomograph
  • Retinal imaging device
  • Photoreceptor analysis
  • Eye imaging
  • Image analysis

Websites

  • incellvu.plInCellVu – Nano-cellular Revolution in Ophthalmology
    Apache

Authorized Representatives

Łukasz Waldemar Kornaszewski age 47 – President of the Management Board

Manner of representation

One member of the management board acting independently is authorized to make declarations of will and sign on behalf of the company.

Supervisory board

Adam Krzysztof Roślewski age 65 – Supervisory Board Member
Edward Aleksander Wylęgała age 66 – Supervisory Board Member
Dawid Mateusz Borycki age 44 – Supervisory Board Member
Jacek Witold Gregorowicz age 71 – Supervisory Board Member
Krzysztof Jassem age 61 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-08-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,582

Competitors

Name
Digital Pathology Team sp. z o.o.
Incepton sp. z o.o.
Smart Tracking sp. z o.o.
Muotech sp. z o.o.
Igness sp. z o.o.
Antmicro Research sp. z o.o.
Skinai sp. z o.o.
DSQ Tech sp. z o.o.
Microanalysis sp. z o.o.
Uplogic sp. z o.o.

Change history

DateEvent
2025-07-10Share capital increase
2025-02-25Address change
2025-02-25Share capital increase
2025-02-24Switch to PKD 2025
2024-05-29Share capital increase

FAQ

Last updated: 2026-07-02